The Use of Computed Tomography in the Diagnosis of Fatty Liver and Abdominal Fat Distribution among a Saudi Population
DOI:
https://doi.org/10.3889/oamjms.2017.187Keywords:
Steatosis, Computed tomography, Liver, SpleenAbstract
BACKGROUND: The pandemic of obesity is striking heavily worldwide and particularly among the affluent Gulf States where it is expected to continue to rise along with its complications.
AIM: To examine the link between liver fat infiltration and abdominal fat amount using plain computer-assisted tomography (CT).
METHODS: Fifty patients visiting the obesity clinic of “King Fahd Specialist Hospital†or Dr Suliman Alhabeeb Hospital between January 2015 and April 2016 were included. Liver and splenic attenuation dimensions were undertaken with three hepatic regions of interests (ROIs) and two ROIs from the spleen. The liver attenuation indices (LAIs) that were measured liver parenchymal attenuation (CTLP), liver/splenic attenuation ratio (LS ratio)and the (3) difference between liver and splenic attenuation (LS dif) and based on this LS dif The patients were grouped as LS dif greater or less than 5. Abdominal fat was evaluated utilising a 3 mm chop CT scan starting from the umbilicus; then computed by a workstation. The abdominal fat was classified as total fat (TF) and the sub-compartments of visceral adipose (fat) (VF), and subcutaneous fat (SF).
RESULTS: Twenty-six of the participants were males. The mean (SD) of the age and BMI was 48 (14.9) years and 32.05 (8.3) kg/m2 respectively.The BMI and body Wt had a moderate negative correlation with the liver attenuation indices CTLP, LS ratio, LS diff (r = -0.417, -0.277, -0.312 and 0.435, -0.297, -0.0297), respectively. A very strong negative correlation between fatty liver, LS ratio and CTLP was found (-0.709, -0.575) respectively.
CONCLUSION: Plain computed tomography can reliably be used as a survey device for fatty liver disease.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87:4-14. https://doi.org/10.1016/j.diabres.2009.10.007 PMid:19896746
Alhyas L, McKay A, Majeed A. Prevalence of Type 2 Diabetes in the States of the Co-Operation Council for the Arab States of the Gulf: A Systematic Review. Sesti G, ed. PLoS ONE. 2012; 7:e40948.
Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology. 2012;5:199-207. https://doi.org/10.1177/1756283X11430859 PMid:22570680 PMCid:PMC3342568
Attar BM, Van Thiel DH. Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorld Journal. 2013; 2013:481893.
Abd El-Kader SM, El-Den Ashmawy EMS. Non-alcoholic fatty liver disease: The diagnosis and management. World Journal of Hepatology. 2015;7:846-858. https://doi.org/10.4254/wjh.v7.i6.846 PMid:25937862 PMCid:PMC4411527
Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci. 2011;48:97-113. https://doi.org/10.3109/10408363.2011.596521 PMid:21875310
Jang S, Lee CH, Choi KM, et al. Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World Journal of Gastroenterology : WJG. 2011;17:3335-3341. https://doi.org/10.3748/wjg.v17.i28.3335 PMid:21876622 PMCid:PMC3160538
Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology : WJG. 2014;20(2):475-485. https://doi.org/10.3748/wjg.v20.i2.475 PMid:24574716 PMCid:PMC3923022
Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol. 2014;20:7718-29. https://doi.org/10.3748/wjg.v20.i24.7718 PMid:24976709 PMCid:PMC4069300
Shores NJ, Link K, Fernandez A, et al. Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients. Digestive Diseases and Sciences. 2011;56:2145-2151. https://doi.org/10.1007/s10620-011-1602-5 PMid:21318585 PMCid:PMC3112485
Saran S, Philip R, Gutch M, Tyagi R, Agroiya P, Gupta KK. Correlation between liver fat content with dyslipidemia and Insulin resistance. Indian Journal of Endocrinology and Metabolism. 2013;17:S355-S357. https://doi.org/10.4103/2230-8210.119620 PMid:24251213 PMCid:PMC3830359
Wells MM, Li Z, Addeman B, et al. Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. Canadian Journal of Gastroenterology & Hepatology. 2016;2016:4930987. https://doi.org/10.1155/2016/4930987 PMid:27446844 PMCid:PMC4904663
WHO. Global Database on Body Mass Index. Approached at http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol. 2003; 149:543-8. https://doi.org/10.1530/eje.0.1490543 PMid:14640995
Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol. 2003; 15:539-43. PMid:12702913
Gaba RC, Knuttinen MG, Brodsky TR, Palestrant S, Omene BO, Owens CA, Bui JT. Hepatic steatosis: correlations of body mass index, CT fat measurements, and liver density with biopsy results. Diagn Interv Radiol. 2012; 18:282-7. PMid:22258794
Anstee QM, McPherson S, Day CP. How big a problem is nonalcoholic fatty liver disease? BMJ. 2011;343:d3897. https://doi.org/10.1136/bmj.d3897 PMid:21768191
Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92:3490–7. https://doi.org/10.1210/jc.2007-0482 PMid:17595248
Shores NJ, Link K, Fernandez A, et al. Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients. Digestive Diseases and Sciences. 2011;56:2145-2151. https://doi.org/10.1007/s10620-011-1602-5 PMid:21318585 PMCid:PMC3112485
Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006; 239:105-12. https://doi.org/10.1148/radiol.2391050361 PMid:16484355
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
